sábado, 6 de noviembre de 2021

Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation - EBioMedicine

Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation - EBioMedicine

No hay comentarios:

Publicar un comentario